Magstim names new chief medical advisor

Magstim has announced the appointment of Dr Linda Carpenter as its new chief medical advisor with immediate effect.

Dr Carpenter's past experience includes spells as professor of psychiatry and human behaviour at Brown University and chief of the mood disorder programme at Butler Hospital, both in Rhode Island.

Her role will be to provide clinician-centric insight into the current and future developments of Magstim's repetitive transcranial magnetic stimulation (rTMS) technology, which was recently approved for the treatment of major depressive disorder in the US in May 2015.

This will give the company an opportunity to significantly increase patient and clinician access to its latest rTMS products across the region, an effort that Dr Carpenter will support.

Robin Davies, chief executive officer of Magstim, said: "Her insight into the treatment of major depressive disorder with rTMS is an invaluable asset for Magstim in the development of innovative solutions for clinicians and patients alike."

The firm's rTMS technology works by stimulating the left dorsolateral prefrontal cortex, thus improving their ability to regulate mood.